I could be very wrong here but I think from what I read in Patrys reporets is that Patrys' apparently has the ability to target particular protiens with its' processes. I.E. Pancreatic cancer and Multiple Myeloma. In yesterdays news a scientist explained that breast cancer in women was due to a certain proein they had identified. If Patrys' product can be tailered to attack (as in MM) we're stratospheric. are we not? Although this reads like a crude beat-up, how else can the question be asked?
Hope for 2016, page-2
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 826219 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1307531 | 4 |
View Market Depth
| Last trade - 10.06am 02/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable